Compound Evidence File
#EC-2026-0594
Oxymetholone (Anadrol) Raw
Filed under Raw Materials. The bureau holds 143 laboratory returns for this compound from 47 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
47 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 10.0 | 10.0 | 11 May 2026 | 6 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 13 Dec 2025 | 13 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 10.0 | 10.0 | 20 Apr 2026 | 8 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 15 Apr 2026 | 12 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 12 Mar 2026 | 13 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 9.9 | 10.0 | 20 May 2026 | 10 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 17 May 2026 | 9 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 26 Jan 2026 | 6 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 10.0 | 10.0 | 10.0 | 7 May 2026 | 22 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 10.0 | 10.0 | 10.0 | 8 Apr 2026 | 4 May 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 10.0 | 10.0 | 10.0 | 8 Apr 2026 | 27 Jun 2026 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 10.0 | 10.0 | 10.0 | 3 Jun 2025 | 3 Jun 2025 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Apr 2026 | 12 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 23 Jan 2026 | 27 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 1 Feb 2026 | 16 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 9.9 | 9.9 | 10.0 | 17 Jan 2026 | 16 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 10.0 | 18 Dec 2025 | 19 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 10.0 | 25 Mar 2026 | 4 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 9.9 | 24 May 2026 | 20 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 6 Jan 2026 | 4 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Mar 2026 | 24 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 10.0 | 11 Feb 2026 | 8 Aug 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 9.9 | 9.9 | 9.9 | 8 Jul 2025 | 8 Jul 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 9.2 | 9.2 | 9.2 | 27 Feb 2025 | 27 Feb 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 9.1 | 8.3 | 10.0 | 25 May 2026 | 25 May 2026 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 9.0 | 9.0 | 9.0 | 11 Jun 2025 | 11 Jun 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.7 | 7.6 | 10.0 | 21 May 2026 | 21 May 2026 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 8.4 | 8.4 | 8.4 | 24 Apr 2025 | 24 Apr 2025 |
| Skye PeptidesCASE #VI-2026-0451 | X | 6 | 8.2 | 6.8 | 9.4 | 11 Jun 2025 | 19 Jan 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.1 | 7.1 | 9.5 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.1 | 6.6 | 9.3 | 24 May 2026 | 24 May 2026 |
| ZhuoYan labCASE #VI-2026-0902 | X | 3 | 7.7 | 7.6 | 7.7 | 27 Feb 2025 | 17 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 7.2 | 6.0 | 8.3 | 24 May 2026 | 24 May 2026 |
| OupeptideCASE #VI-2026-0435 | X | 13 | 6.9 | 4.5 | 8.4 | 2 Apr 2025 | 24 May 2026 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 3 | 6.8 | 4.8 | 9.6 | 2 Apr 2025 | 17 May 2026 |
| Astro PeptidesCASE #VI-2026-0424 | X | 1 | 6.6 | 6.6 | 6.6 | 17 Dec 2024 | 17 Dec 2024 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 6.4 | 6.4 | 6.4 | 25 Apr 2025 | 25 Apr 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 3 | 6.2 | 5.2 | 7.3 | 3 Jun 2025 | 23 May 2026 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 1 | 5.7 | 5.7 | 5.7 | 7 May 2025 | 7 May 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 5.5 | 5.5 | 5.5 | 3 Jun 2025 | 3 Jun 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 2 | 4.1 | 1.4 | 6.8 | 13 Feb 2025 | 25 May 2026 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 3.3 | 3.3 | 3.3 | 27 Feb 2025 | 27 Feb 2025 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 3.3 | 3.3 | 3.3 | 7 May 2025 | 7 May 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 3.2 | 3.2 | 3.2 | 13 Feb 2025 | 13 Feb 2025 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 1.3 | 1.3 | 1.3 | 13 Feb 2025 | 13 Feb 2025 |
Open any subject to view the batch-level evidence for Oxymetholone (Anadrol) Raw alone.